Evidence map›Paper›PMID 40603896›Full record

ArticleScientific reports2025

Irradiation of prostate cancer alters circulating small extracellular vesicle functions.

Aejaz Sayeed, Vaughn Garcia, Cecilia E Verrillo, Rachel M DeRita, Md Niamat Hossain, Shiv Ram Krishn, Samuel Sey, Christopher D Shields, Adrian D Altieri, Qin Liu and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aejaz Sayeed *Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Vaughn Garcia *Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Cecilia E Verrillo *Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Rachel M DeRitaProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Md Niamat HossainProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Shiv Ram KrishnProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Samuel SeyProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Christopher D ShieldsProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Adrian D AltieriProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Qin LiuMolecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
Khalid Sossey-AlaouiDepartment of Medicine, School of Medicine MetroHealth Medical Center Rammelkamp Center for Research, Case Western Reserve University, Cleveland, OH, USA.
William K KellyProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA.
Lucia R LanguinoProstate Cancer Discovery and Development Program, Thomas Jefferson University, Bluemle Life Sciences Building, 233 South 10th Street Suite 506, Philadelphia, PA, 19107, USA. lucia.languino@jefferson.edu.

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Aaron Robert Goldman · 1985 to 2026
$75.9M
TNBC in AA WomenR01CA226921 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SOSSEY-ALAOUI, KHALID · 2019 to 2023
$2.3M
Integrin-mediated mechanisms of prostate cancer progressionR01CA224769 · NCI · THOMAS JEFFERSON UNIVERSITY · PI LANGUINO, LUCIA R. · 2018 to 2022
$2.0M
American Cancer Society (ACS)-IRG-08-060-04NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA224769NCI NIH HHS R01 CA226921NIH HHS NCI-P01-140043NIH HHS R01CA226921Pennsylvania Department of Health SAP 4100072566Thomas Jefferson University Biome AwardU.S. Department of Defense DOD-PRCP W81XWH2210826
6 · The paper itself

Abstract

It is known that β1 integrins and a downstream signaling molecule c-Src are upregulated in prostate cancer (PrCa) tissues, are co-expressed in circulating small extracellular vesicles (sEVs) and contribute to cancer progression. Here, we demonstrate that sEVs from PrCa patients show robust expression of both β1 integrins and c-Src. The impact of irradiation, a widely used therapy for the treatment of PrCa, on circulating sEVs is however not fully understood. We show that sEVs isolated from the plasma of transgenic adenocarcinoma of mouse prostate (TRAMP) mice, stimulate migration and anchorage-independent growth of recipient cancer cells, but sEVs are not active when isolated from mice that had undergone pelvic irradiation of PrCa. In addition, circulating sEVs from irradiated mice do not show co-sedimentation of β1 integrins and either c-Src or sEV markers, previously observed in sEVs from non-irradiated mice, but show reduced expression of c-Src. To rule out that the observed effect of irradiation on sEVs is not due to reduced tumor size, we demonstrate that irradiation of PrCa cells in vitro diminishes sEV capability to stimulate recipient cell anchorage-independent growth. Irradiation-induced changes in the composition of circulating sEVs illustrate a tumor-suppressive effect of radiation, which may have potential therapeutic implications.

Indexed as

Extracellular VesiclesProstatic NeoplasmsAdenocarcinomaAnimalsCell Line, TumorCell MovementCSK Tyrosine-Protein KinaseHumansIntegrin beta1MaleMiceMice, TransgenicCSK Tyrosine-Protein KinaseIntegrin beta1c-SrcIrradiationProstate cancerSmall extracellular vesiclesTRAMPβ1 integrin subunit

Identifiers

PMID40603896
PMCPMC12223255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.